Cord blood lymphocytes, monocytes, and neutrophils from newborns were shown to mediate antibody-dependent cellular cytotoxicity (ADCC) against influenza virus-infected cells. Antibody mediating ADCC was detectable in cord plasma, indicating that all components necessary for ADCC against influenza virus-infected cells are present in newborns. Among adult lymphocytes, two effector cell populations of influenza ADCC are recognized: non-T and T-y cells. Each of these cell types expresses an antigen recognized by monoclonal HNK-1 antibody. The proportion of HNK-1 antigen-positive lymphocytes in cord blood was markedly lower than in adult blood; furthermore, ADCC was mediated by cord blood lymphocytes which were HNK-1 negative. By lymphocyte fractionation, the effector lymphocytes in cord blood were, as in adults, non-T and T-y cells, suggesting that HNK-1 antigen is not expressed on these cell lineages in newborns.
tal lymphocytes mediate only low levels of cytotoxicity. There are conflicting observations on the ability of human neonatal lymphocytes to mediate ADCC (4, 8, 10, 11, 14) and natural killer cytotoxicity (3, 7, 13, 17) . In the present study cord blood lymphocytes were only slightly less effective than adult lymphocytes in mediating ADCC against influenza virus-infected cells. This suggests that neonatal lymphocytes, although not expressing the HNK-1 antigen, can mediate ADCC in a viral system. MATERIALS AND METHODS Cell preparation. Umbilical cord blood was obtained from 11 normal newborns at delivery. Peripheral blood was obtained form seven healthy adult donors. Plasticnonadherent lymphocytes, monocytes (plastic adherent), and neutrophils were prepared as previously described (Hashimoto et al., in press). Briefly, heparinized blood was subjected to Ficoll-Hypaque density centrifugation. Mononuclear cells were taken from the interface and separated into adherent and nonadherent populations by being placed for 2 h at 37°C in a plastic flask precoated with fetal calf serum. Neutrophils were obtained from the Ficoll-Hypaque pellet, with contaminating red cells lysed hypotonically.
Plastic-nonadherent and nylon wool-passed lymphocytes were depleted or enriched for HNK-1 antigenexpressing cells. The monoclonal HNK-1 antibody was kindly supplied by T. Abo, University of Alabama, Birmingham. To deplete HNK-1-positive cells, 3 x 10 lymphocytes were incubated with 200 ,ul of HNK-1 antibody (250 ,ug/ml) for 20 min at room temperature. Fresh rabbit serum was then added at a final dilution of 1:8, and incubation was carried out for 60 min more at 37°C.
HNK-1-positive cells were enriched by adherence to an antibody-coated plastic dish. A plastic dish (no. 3506; Costar, Cambridge, Mass.) was filled with 1 ml of HNK-1 antibody (1 mg/ml), left overnight at 4°C, and washed well with phosphate-buffered saline before use. Lymphocytes (2 x 107) were allowed to adhere to the antibody-coated dish at 37°C for 60 min. After removal of nonadherent cells, adherent cells were scraped, washed once, and used in the assay. Cord blood lymphocytes were separated into T and non-T cells with E rosette fractionation (5), using neuraminidase-treated sheep erythrocytes as E (5) . Each cell population was suspended in RPMI 1640 with 10%)o agamma calf serum (KC Biologicals, Lenexa, Kansas).
Virus. The ADCC assay was performed by using 5tCr-labeled and influenza A/Alaska/6/77 (H3N2) virus-infected BHK-21 cells, as described previously (Hashimoto et al., in press). Briefly, 100 RI of infected cells (5 x 103) was incubated with 25 ,l1 of influenza A H3N2 immune human serum and 100 ,ul of effector cells at effector/target (E/T) ratios offrom 6 to 50 for 6 h at 37°C. The percentage of specific immune release (SIR) = (A -B)/(M -B) x 100, where A is the count from the cell mixture with antibody, B is the count from the cell mixture without antibody, and M is the average count of maximum release. Samples were assayed in triplicate, or in duplicate when the number of effector cells was insufficient.
Immunofluorescence assays. Cells reactive with HNK-1 antibody were enumerated by an indirect immunofluorescence assay as described elsewhere (1). The secondary antibody was fluorescein isothiocyanate-conjugated goat anti-mouse ,u chain-specific antibody (Cappel Laboratories, Cochranville, Pa.) absorbed with washed, pooled human lymphocytes.
RESULTS
Although the mean ADCC activity of cord blood lymphocytes was significantly lower than that of adult lymphocytes at all E/T ratios (P < 0.01 atE/T = 50, 25,andl2,andP<0.O5atE/T = 6), cord blood lymphocytes from all 11 newborns showed considerable ADCC activity against influenza virus-infected cells, with 14.7 to 52.0%o SIR at an E/T ratio of 50:1 (Fig. 1) . Additionally, in Fig. 1 Table 2) . Neutrophils (Table 3 ) and, to a lesser extent, monocytes (Table 2 ) from cord blood mediate ADCC. A considerable amount of antibody capable of mediating ADCC was detectable in each sample of cord blood. Cord blood serum with adult lymphocytes, at an E/T ratio of 100:1, could be diluted to from 1:90 to 1:3,780 before SIR dropped below 10%. Depletion of HNK-1-positive cells by treatment with HNK-1 antibody and complement has previously been shown to diminish ADCC activity in adult peripheral blood lymphocytes (Hashimoto et al., in press). Therefore, cord blood and adult lymphocytes were depleted of HNK-1-positive cells by complement lysis (Table 4) . Greater than 90% of HNK-1-positive cells were effectively eliminated from adult lymphocytes, with a concomitant decrease in ADCC activity. In cord blood, the HNK-1-positive cells were reduced to the lower limit of detection, i.e., less than 1 HNK-1-positive cell in 200 lymphocytes, without an alteration in the SIR at multiple E/T ratios. Treatment with complement or HNK-1 antibody alone did not alter the cytotoxicity (the latter data not shown).
Enrichment of HNK-1-positive cells was successfully accomplished with adult lymphocytes by using HNK-1 antibody-coated plates, with the anticipated rise in ADCC activity (Table 5 ). Insufficient numbers of cord blood lymphocytes attached to the HNK-1 antibody-coated plates to allow analysis, another indication of the lack of expression of this antigen in cord blood.
Two cord blood samples were fractionated into non-T and T cells. It had previously been shown with adult lymphocytes that ADCC activity was present in both fractions. That appeared to be the case in cord blood lymphocytes as well (Table 6) , although the relatively low SIR in the (8, 10, 14) . However, in a number of nonviral systems, cord blood lymphocytes demonstrate diminished activity when compared with adult cells (2-4, 11, 13, 17). The apparent difference between viral and nonviral systems appears most likely to be due to differing assay systems, many of which employed small numbers of specimens and low E/T ratios, rather than to a fundamental difference in cytotoxic behavior in viral and nonviral systems.
Our observations suggest that lymphocyte populations other than those in the HNK-1-positive lineage mediate ADCC in cord blood or that the HNK-1 antigen is not fully expressed in neonates. Cells mediating natural killer and ADCC reactions have a high cytoplasmic/nuclear ratio and azurophilic granules in the cytoplasm and are called large granular lymphocytes (12, 16) . Although we did not attempt to quantitate this cell type, others have reported equivalent percentages of these cells in cord and adult mononuclear cells (15) . This observation coupled with our results that, as in adults, neonatal lymphocytes mediating ADCC are in both null cell and T-y cell populations suggests that cells in the same lineage mediate ADCC at both ages. HNK-1 antigen expression may be a postnatal maturational event.
All of the components necesssary to mediate ADCC should be present in neonates. In spite of this, in an experimental herpes simplex virus infection of newborn mice, adult mononuclear cells and antibody were more effective at preventing disease than were neonatal cells with the same antibody (9) . Further such experiments designed to test the competency and importance of the ADCC defense mechanism in both neonates and adults are needed.
